Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan

January 9, 2023

https://www.globenewswire.com/news-release/2023/01/09/2585017/30925/en/Agile-Therapeutics-Provides-Updates-on-2022-Twirla-Performance-and-2023-Commercial-Plan.html

Fourth Quarter 2022 Twirla Factory Sales Expected to Increase Approximately 30% from Third Quarter 2022

Full Year 2022 Factory Sales Expected to Increase Approximately 232% from Full Year 2021

Read more at globenewswire.com

Related news for (AGRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.